Has Pavan Bhat, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,224 in general payments to Pavan Bhat, MD across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pavan Bhat, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pavan Bhat, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pavan Bhat, MD

Advanced Heart Failure and Transplant Cardiology · Cleveland, OHNPI 1235492505

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 90.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $8,216 and has fallen 72.1% since, to $2,294 in 2025.

$16,224in general payments, 2019–2025

Across 97 payments — averaging $167.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$15K
Medtronic$1K
Impulse Dynamics (USA) Inc.$174
Alnylam Pharmaceuticals Inc.$115
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$104
Bayer$23
plus $45 from 2 others

$20,800in research payments, 2019–2025

Across 1 payment — averaging $20,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Briohealth Solutions, Inc.$21K

What the payments were for

Consulting fees$3,37521%
Travel & lodging$8,15250%
Food & beverage$4,69729%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	81	$14,635
Medtronic	10	$1,128
Impulse Dynamics (USA) Inc.	1	$174
Alnylam Pharmaceuticals Inc.	1	$115
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$104
Bayer	1	$23
Abiomed	1	$22
Blue Earth Diagnostics	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THORATEC HEARTMATE 3 LVAS IMPLANT KIT$11,204
Ensite Cardiac Mapping System$1,023
OPTIMIZER$348
MitraClip$180
AMVUTTRA$115
CARDIOMEMS$109
HeartMate 3 Left Ventricular Dev$109
LifeVest$104

How this compares

$16,224 in reported general payments places this provider in the 65th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.

See all advanced heart failure and transplant cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$97,452

Medicare patients

484

Services billed

1,295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyndamaxTafamidis	140	$3,211,857
EntrestoSacubitril/Valsartan	446	$527,147
JardianceEmpagliflozin	343	$381,512
VyndaqelTafamidis Meglumine	13	$268,581
EliquisApixaban	148	$150,360
FarxigaDapagliflozin Propanediol	87	$99,082
XareltoRivaroxaban	25	$30,507
Isosorbide Dinitrate	20	$7,238
Metoprolol Succinate	291	$4,366
Eplerenone	43	$3,961
Torsemide	85	$1,974
Atorvastatin Calcium	132	$1,478
Spironolactone	274	$1,466
Valsartan	61	$1,411
Amiodarone Hcl	32	$1,241

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Cleveland

Andres Carmona RubioCleveland$27K
Robert MontgomeryCleveland$9K
Sanjeeb BhattacharyaCleveland$7K
Tuoyo Mene-AfejukuCleveland$6K
Ran LeeCleveland$5K
Chonyang AlbertCleveland$4K
Amanda VestCleveland$4K
Leon ZhouCleveland$3K
Karlee HoffmanCleveland$2K
Michael HillCleveland$2K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →